CN100509014C - Medicament for treating mammitis - Google Patents
Medicament for treating mammitis Download PDFInfo
- Publication number
- CN100509014C CN100509014C CNB2006101283107A CN200610128310A CN100509014C CN 100509014 C CN100509014 C CN 100509014C CN B2006101283107 A CNB2006101283107 A CN B2006101283107A CN 200610128310 A CN200610128310 A CN 200610128310A CN 100509014 C CN100509014 C CN 100509014C
- Authority
- CN
- China
- Prior art keywords
- radix
- root
- pericarpium citri
- medicament
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating mammitis which is prepared from the following raw materials (by weight proportion): Chinese honeylocust spine, dandelion, honeysuckle, capsule of weeping forsythia, Bupleurum root, green tangerine orange peel, dried orange peel, Chinese angelica root, radix paeoniae rubrathe, dried rehmannia root, figwirt root, root of herbaceous peony, globe thistle, seed of cowherb, oyster shell, astragalus root, licorice root.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of mastopathy, relate in particular to a kind of medicine for the treatment of mastitis.
Background technology
Mastitis are a kind of anxious, painful big disease of falling ill, the mastitis pilosity is born in age of sucking in puerperal, the primipara particularly more to be seen, system because of trimester of pregnancy not to the nipple work of getting ready, or when sucking, nipple is caused due to the damage because of the baby, bacterial infection is by Supramammillary small gap, enter lactiferous ducts and lobules of mammary gland, or the process lymph is invaded the gap tissue of lobules of mammary gland, and cause acute inflammatory reaction, its pathogenic bacterium are staphylococcus or streptococcus, are a kind of commonly encountered diseases of women breast-feeding their children, account for 5% of cystic hyperplasia of breast.Different phase according to the development of breast local inflammation can be divided into three types: 1 a, type: massive inflammatory cells infiltrated in the acute simplex inflammatory phase, mammary gland tissue, the general limitation of extent of disease has human milk silt in mammary gland and the conduit.2, two types: the acute festering type areolar tissue inflammation phase, inflammation further develops, and causes local organization destruction, and a large amount of neutrophilic granulocyte necrosis, liquefaction form suppuration kitchen range not of uniform size.3, three types: abscess forms the phase, continues development as inflammation, and a large amount of necrosis of local organization, liquefaction, focus of infection not of uniform size merge the formation abscess mutually.Because cause of disease complexity, complication is many, at present domestic also do not have with strong points, the single variety medicine of instant effect.Western medical treatment mainly be diagnosis clear and definite after, venous transfusion surgical operation therapy in addition cuts treatment to reach radical cure, Chinese medicine decoction or externally applied plaster treatment are adopted in Chinese traditional treatment more, grow the course of treatment, take effect slowly, easily repeatedly.
Summary of the invention
The medicine that the purpose of this invention is to provide good, the with strong points treatment mastitis of a kind of therapeutic effect.
The present invention realizes above-mentioned purpose by the following technical solutions: a kind of medicine for the treatment of mastitis, and it is the medicament of being made by the raw material of following parts by weight:
Spina Gleditsiae 20~60 Herba Taraxacis 15~40 Flos Lonicerae 10~30 Fructus Forsythiaes 10~30
Radix Bupleuri 10~15 Pericarpium Citri Reticulatae Virides 6~15 Pericarpium Citri Reticulataes 6~15 Radix Angelicae Sinensis 10~20
Radix Paeoniae Rubra 10~15 Radix Rehmanniae 10~20 Radix Scrophulariae 10~20 Radix Paeoniae Albas 10~20
Radix Rhapontici 10~15 kings do not stay 10~15 Concha Ostreaes, 10~30 Radixs Astragali 10~30
Radix Glycyrrhizae 5~10.
The medicine of treatment mastitis, the preferably medicament of making by the raw material of following parts by weight:
Spina Gleditsiae 40~60 Herba Taraxacis 20~40 Flos Lonicerae 20~30 Fructus Forsythiaes 20~30
Radix Bupleuri 10~12 Pericarpium Citri Reticulatae Virides 8~12 Pericarpium Citri Reticulataes 8~12 Radix Angelicae Sinensis 10~15
Radix Paeoniae Rubra 12~15 Radix Rehmanniae 12~18 Radix Scrophulariae 12~18 Radix Paeoniae Albas 10~15
Radix Rhapontici 12~15 kings do not stay 10~12 Concha Ostreaes, 15~25 Radixs Astragali 15~25
Radix Glycyrrhizae 5~8.
The medicine of treatment mastitis, the most preferably medicament of making by the raw material of following parts by weight:
Spina Gleditsiae 50 Herba Taraxacis 30 Flos Lonicerae 30 Fructus Forsythiaes 30
Radix Bupleuri 10 Pericarpium Citri Reticulatae Virides 10 Pericarpium Citri Reticulataes 10 Radix Angelicae Sinensis 12
Radix Paeoniae Rubra 12 Radix Rehmanniae 15 Radix Scrophulariae 15 Radix Paeoniae Albas 10
Radix Rhapontici 12 kings do not stay 10 Concha Ostreaes, 20 Radixs Astragali 20
Radix Glycyrrhizae 5.
Medicament of the present invention is a said dosage form on any pharmaceutics.
The preparation of common formulations:
1, mixture: above-mentioned each component drug is mixed, decoct with water leaching, behind fried liquid placement certain hour, leach insoluble matter, collect filtrate concentrating, the packing of concentrated solution cold filtration.
2, capsule: with above-mentioned each material medicine drying and crushing, mix, sieving incapsulates in the shell.
3, pill: above-mentioned each component drug is ground into smalls, adds Mel and make honeyed pill.
Among the present invention, the hot temperature of Spina Gleditsiae is nontoxic to be principal agent, the eliminating carbuncle eliminating stagnation; Be aided with sweet cold Herba Taraxaci, Flos Lonicerae, Fructus Forsythiae heat-clearing and toxic substances removing, the power of enhancing eliminating carbuncle; Radix Bupleuri, Pericarpium Citri Reticulatae Viride, Pericarpium Citri Reticulatae depressed liver-energy dispersing and QI regulating, inducting the medicines into affected channel is to increase the usefulness of principal agent eliminating stagnation; Assistant Radix Angelicae Sinensis, Radix Paeoniae Rubra, the Radix Paeoniae Alba, the Radix Rehmanniae, Radix Scrophulariae cooling blood and removing stasis, easing the affected liver to relieve pain is to help the principal agent eliminating stagnation, the double branch waste heat that purifies the blood; Help Radix Rhapontici again, Semen Vaccariae is gone into liver, stomach two warps, with the heat-clearing and toxic substances removing lactogenesis eliminating stagnation of holding concurrently, makes heresy that outlet be arranged; Radix Astragali QI invigorating and body resistance strengthening in addition, the effect of Concha Ostreae eliminating stagnation, the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is played heat-clearing and toxic substances removing altogether, eliminating carbuncle eliminating stagnation, soothing the liver lactogenesis, blood-activating analgetic, thus reaching treating both the principal and secondary aspects of a disease, Chinese medicine instant effect of the present invention, short treating period, relapse rate be low, have no side effect.
The specific embodiment
The present invention enumerates 6 embodiment, and the parts by weight of each embodiment component see the following form:
Component | Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 |
Spina Gleditsiae | 50 | 35 | 40 | 20 | 60 | 45 |
Herba Taraxaci | 30 | 40 | 15 | 35 | 25 | 20 |
Flos Lonicerae | 30 | 10 | 15 | 20 | 30 | 25 |
Fructus Forsythiae | 30 | 10 | 20 | 25 | 30 | 15 |
Radix Bupleuri | 10 | 12 | 10 | 15 | 10 | 12 |
Pericarpium Citri Reticulatae Viride | 10 | 15 | 6 | 10 | 8 | 12 |
Pericarpium Citri Reticulatae | 10 | 12 | 6 | 15 | 8 | 10 |
Radix Angelicae Sinensis | 12 | 10 | 15 | 20 | 18 | 12 |
Radix Paeoniae Rubra | 12 | 10 | 15 | 12 | 15 | 10 |
The Radix Rehmanniae | 15 | 10 | 15 | 20 | 18 | 12 |
Radix Scrophulariae | 15 | 20 | 15 | 12 | 18 | 10 |
The Radix Paeoniae Alba | 10 | 20 | 15 | 12 | 15 | 18 |
Radix Rhapontici | 12 | 10 | 15 | 12 | 10 | 12 |
The king does not stay | 10 | 12 | 15 | 10 | 12 | 15 |
Concha Ostreae | 20 | 30 | 10 | 25 | 15 | 18 |
The Radix Astragali | 20 | 10 | 20 | 15 | 30 | 25 |
Radix Glycyrrhizae | 5 | 6 | 8 | 10 | 9 | 8 |
Chinese medicine of the present invention is applied to clinical experiment, the experiment case is totally 59 examples, all check with the inspection of mammary gland noctovisor scan, breast molybdenum target X ray examination, ultrasound diagnosis and auxiliary blood RT, get rid of the inflammatory breast carcinoma, the pregnant phase or age of sucking breast carcinoma, case is the mastitis patient, a type (+) 40 examples wherein, two types (++), 13 examples, three types (+++) 6 examples, merge cyclomastopathy 4 examples, merge fibroma 2 examples, take herb mixture of the present invention, dose: each 10~20ml, 2~3 times on the one, 10 days course of treatment, totally 3 courses of treatment.
Therapeutic outcome sees the following form:
One type (+) | Two types (++) | Three types (+++) | Add up to | |
Case | 40 examples | 13 examples | 6 examples | 59 examples |
Cure | 39 examples | 9 examples | 0 example | 48 examples |
Produce effects | 0 example | 1 example | 2 examples | 3 examples |
Effectively | 1 example | 2 examples | 3 examples | 6 examples |
Invalid | 0 example | 1 example | 1 example | 2 examples |
As can be known from the above table, cure 48 examples, account for 81.4% of total routine number; Produce effects 3 examples account for 5.1% of total routine number; Effective 6 examples account for 10.2% of total routine number; Invalid 2 examples account for 3.3% of total routine number; Total effective rate is 96.7%.
Claims (4)
1, a kind of medicine for the treatment of mastitis is characterized in that, it is the medicament of being made by the raw material of following parts by weight:
Spina Gleditsiae 20~60 Herba Taraxacis 15~40 Flos Loniceraes 10~30 Fructus Forsythiaes 10~30
Radix Bupleuri 10~15 Pericarpium Citri Reticulatae Virides 6~15 Pericarpium Citri Reticulataes 6~15 Radix Angelicae Sinensis 10~20
Radix Paeoniae Rubra 10~15 Radix Rehmanniae 10~20 Radix Scrophulariaes 10~20 Radix Paeoniae Albas 10~20
Radix Rhapontici 10~15 Semen Vaccariae 10~15 Concha Ostreaes 10~30 Radixs Astragali 10~30
Radix Glycyrrhizae 5~10.
2, treat the medicine of mastitis according to claim 1, it is characterized in that, it is the medicament of being made by the raw material of following parts by weight:
Spina Gleditsiae 40~60 Herba Taraxacis 20~40 Flos Loniceraes 20~30 Fructus Forsythiaes 20~30
Radix Bupleuri 10~12 Pericarpium Citri Reticulatae Virides 8~12 Pericarpium Citri Reticulataes 8~12 Radix Angelicae Sinensis 10~15
Radix Paeoniae Rubra 12~15 Radix Rehmanniae 12~18 Radix Scrophulariaes 12~18 Radix Paeoniae Albas 10~15
Radix Rhapontici 12~15 Semen Vaccariae 10~12 Concha Ostreaes 15~25 Radixs Astragali 15~25
Radix Glycyrrhizae 5~8.
3, treat the medicine of mastitis according to claim 1, it is characterized in that, it is the medicament of being made by the raw material of following parts by weight:
Spina Gleditsiae 50 Herba Taraxacis 30 Flos Loniceraes 30 Fructus Forsythiaes 30
Radix Bupleuri 10 Pericarpium Citri Reticulatae Virides 10 Pericarpium Citri Reticulataes 10 Radix Angelicae Sinensis 12
Radix Paeoniae Rubra 12 Radix Rehmanniae 15 Radix Scrophulariaes 15 Radix Paeoniae Albas 10
Radix Rhapontici 12 Semen Vaccariae 10 Concha Ostreaes 20 Radixs Astragali 20
Radix Glycyrrhizae 5.
4, as the medicine of treatment mastitis as described in any one of the claim 1~3, it is characterized in that described medicament is a said dosage form on any pharmaceutics.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101283107A CN100509014C (en) | 2006-11-30 | 2006-11-30 | Medicament for treating mammitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101283107A CN100509014C (en) | 2006-11-30 | 2006-11-30 | Medicament for treating mammitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1970003A CN1970003A (en) | 2007-05-30 |
CN100509014C true CN100509014C (en) | 2009-07-08 |
Family
ID=38111151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101283107A Expired - Fee Related CN100509014C (en) | 2006-11-30 | 2006-11-30 | Medicament for treating mammitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100509014C (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101455772B (en) * | 2009-01-05 | 2011-03-16 | 李凤霞 | Preparation method of traditional Chinese medicine for treating gastric heat type acute mastitis |
CN102357116B (en) * | 2011-10-22 | 2013-05-01 | 宁波市江北区达友生物科技有限公司 | Healthcare product for mammitis of milch goats |
CN102579912B (en) * | 2012-04-01 | 2013-08-21 | 李佃场 | Chinese medicinal capsules special for treating acute mastitis and preparation method thereof |
CN102697984B (en) * | 2012-06-01 | 2014-08-06 | 薛冬梅 | Chinese medicinal external application preparation for treating acute mastitis |
CN102784304B (en) * | 2012-08-11 | 2013-11-13 | 谭玉金 | Traditional Chinese medicine composition for treating acute mastitis |
CN103099906B (en) * | 2013-03-04 | 2014-09-03 | 滕绍然 | Traditional Chinese medicine composition for treating acute mastitis |
CN103751497B (en) * | 2013-12-31 | 2016-05-25 | 李政 | A kind of medicine for the treatment of mastitis and preparation method thereof |
CN103961528A (en) * | 2014-05-05 | 2014-08-06 | 魏国 | Breast pain stasis removing decoction for treating acute mastitis |
CN104027489A (en) * | 2014-05-15 | 2014-09-10 | 当涂县科辉商贸有限公司 | Traditional Chinese medicine preparation for treating acute mastitis |
CN104189251B (en) * | 2014-08-19 | 2018-08-14 | 大连圣弘医药有限公司 | The Chinese medicine composition and preparation method thereof of the treatment proliferation of mammary gland, benign breast tumor |
CN104324111B (en) * | 2014-10-10 | 2016-06-29 | 青岛嘉瑞生物技术有限公司 | A kind of Chinese herbal feed additive preventing milch cow puerperal mastitis |
CN104286584A (en) * | 2014-11-05 | 2015-01-21 | 仁怀市青龙腾达养殖场 | Beef cattle feed with addition of Chinese medicinal composition |
CN105311563A (en) * | 2015-10-29 | 2016-02-10 | 陈光辉 | Medicine for treating mastitis |
CN107375569A (en) * | 2017-08-01 | 2017-11-24 | 张培芝 | A kind of Chinese medicine composition for treating mastitis |
-
2006
- 2006-11-30 CN CNB2006101283107A patent/CN100509014C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1970003A (en) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100509014C (en) | Medicament for treating mammitis | |
CN102151325B (en) | Traditional Chinese medicine for treating breast diseases | |
CN102727832B (en) | Chinese medicinal preparation for treating breast diseases and uterine fibroid and preparation method thereof | |
CN1315525C (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
CN101524464B (en) | Pure traditional Chinese medicine composition for treating female breast diseases and pure traditional Chinese medicine preparation prepared thereby | |
CN101904977B (en) | Medicament for treating mastitis and preparation method thereof | |
CN101444612B (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
CN102940853A (en) | Navel paste for treating mammary gland hyperplasia diseases | |
CN102908603A (en) | Chinese medicament for treating hyperplasia of mammary glands | |
CN102552432A (en) | External Chinese medicinal herb for treating mastitis | |
CN102100872A (en) | Chinese medicine preparation for treating mastitis | |
CN102038911A (en) | Traditional Chinese medicine preparation for treating acute mastitis | |
CN102671141B (en) | Chinese medicine for curing hyperplasia of mammary glands | |
CN101085308B (en) | Oral administration traditional Chinese medicine decoction for treating mammary cancer | |
CN103385999B (en) | Chinese medicine composition for treating acute mastitis | |
CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
CN102552572A (en) | Chinese medicine for treating appendicitis | |
CN105194584A (en) | Medicine for treating dysmenorrhea | |
CN102451378A (en) | Uterus health capsule for treating gynopathy | |
CN1298382C (en) | Chinese materia medica preparation for curing cholecystitis and preparation method | |
CN102697984A (en) | Chinese medicinal external application preparation for treating acute mastitis | |
CN104606639B (en) | A kind of Chinese medicine for treating acute mastitis milk obstruction | |
CN1060078C (en) | Chinese herbal medicine composition for curing malignant lymphoma | |
CN105770400A (en) | Traditional Chinese medicine composition for treating puerperal infection | |
CN1970053A (en) | Medicament for treating pain of breasts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090708 Termination date: 20091230 |